402 related articles for article (PubMed ID: 11519849)
1. Genetic basis of pituitary adenoma invasiveness: a review.
Suhardja A; Kovacs K; Rutka J
J Neurooncol; 2001 May; 52(3):195-204. PubMed ID: 11519849
[TBL] [Abstract][Full Text] [Related]
2. Purine-binding factor (nm23) gene expression in pituitary tumors: marker of adenoma invasiveness.
Takino H; Herman V; Weiss M; Melmed S
J Clin Endocrinol Metab; 1995 May; 80(5):1733-8. PubMed ID: 7745027
[TBL] [Abstract][Full Text] [Related]
3. Analysis of oncogenes and tumor suppressor genes in human breast cancer.
Yamashita H; Kobayashi S; Iwase H; Itoh Y; Kuzushima T; Iwata H; Itoh K; Naito A; Yamashita T; Masaoka A
Jpn J Cancer Res; 1993 Aug; 84(8):871-8. PubMed ID: 8104920
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathogenesis of pituitary adenomas: a review.
Suhardja AS; Kovacs KT; Rutka JT
Acta Neurochir (Wien); 1999; 141(7):729-36. PubMed ID: 10481784
[TBL] [Abstract][Full Text] [Related]
5. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53.
Ambros RA; Vigna PA; Figge J; Kallakury BV; Mastrangelo A; Eastman AY; Malfetano J; Figge HL; Ross JS
Cancer; 1994 Mar; 73(6):1686-92. PubMed ID: 8156496
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of molecular genetic changes in sporadic invasive pituitary adenomas.
Nam DH; Song SY; Park K; Kim MH; Suh YL; Lee JI; Kim JS; Hong SC; Shin HJ; Park K; Eoh W; Kim JH
Exp Mol Med; 2001 Sep; 33(3):111-6. PubMed ID: 11642545
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
8. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.
Yang X; Zhang Z; Jia C; Li J; Yin L; Jiang S
Gynecol Oncol; 2002 Jun; 85(3):438-44. PubMed ID: 12051871
[TBL] [Abstract][Full Text] [Related]
9. Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: with relation to tumor size and invasiveness.
Tang Z; Qin L; Wang X; Zhou G; Liao Y; Weng Y; Jiang X; Lin Z; Liu K; Ye S
Chin Med J (Engl); 1998 Apr; 111(4):313-8. PubMed ID: 10374394
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic studies of sporadic pituitary tumors.
Boggild MD; Jenkinson S; Pistorello M; Boscaro M; Scanarini M; McTernan P; Perrett CW; Thakker RV; Clayton RN
J Clin Endocrinol Metab; 1994 Feb; 78(2):387-92. PubMed ID: 8106627
[TBL] [Abstract][Full Text] [Related]
11. Oncogenes and tumor-suppressor genes.
Lehman TA; Reddel R; Peiifer AM; Spillare E; Kaighn ME; Weston A; Gerwin BI; Harris CC
Environ Health Perspect; 1991 Jun; 93():133-44. PubMed ID: 1685442
[TBL] [Abstract][Full Text] [Related]
12. Cellular alterations in pituitary tumors.
Spada A; Vallar L; Faglia G
Eur J Endocrinol; 1994 Jan; 130(1):43-52. PubMed ID: 7907260
[TBL] [Abstract][Full Text] [Related]
13. c-myc, ras p21 and p53 expression in pleomorphic adenoma and its malignant form of the human salivary glands.
Deguchi H; Hamano H; Hayashi Y
Acta Pathol Jpn; 1993; 43(7-8):413-22. PubMed ID: 8396843
[TBL] [Abstract][Full Text] [Related]
14. Pituitary adenoma pathogenesis: an update.
Rostad S
Curr Opin Endocrinol Diabetes Obes; 2012 Aug; 19(4):322-7. PubMed ID: 22617628
[TBL] [Abstract][Full Text] [Related]
15. Genetic abnormalities of cell proliferation, invasion and metastasis, with special reference to gynaecological cancers.
Sherbet GV; Patil D
Anticancer Res; 2003; 23(2B):1357-71. PubMed ID: 12820395
[TBL] [Abstract][Full Text] [Related]
16. NM23/Nucleoside diphosphate kinase as a transcriptional activator of c-myc.
Postel EH
Curr Top Microbiol Immunol; 1996; 213 ( Pt 2)():233-52. PubMed ID: 9053293
[No Abstract] [Full Text] [Related]
17. Influence of c-myc on the progression of human breast cancer.
Watson PH; Singh R; Hole AK
Curr Top Microbiol Immunol; 1996; 213 ( Pt 2)():267-83. PubMed ID: 9053295
[No Abstract] [Full Text] [Related]
18. c-myc, c-erb-B2, nm23 and p53 expression in human endometriosis.
Schneider J; Jimenez E; Rodriguez F; del Tanago JG
Oncol Rep; 1998; 5(1):49-52. PubMed ID: 9458291
[TBL] [Abstract][Full Text] [Related]
19. Genetic interaction between Rb and N-ras: differentiation control and metastasis.
Takahashi C; Ewen ME
Cancer Res; 2006 Oct; 66(19):9345-8. PubMed ID: 17018584
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations.
Cesarman E; Chadburn A; Inghirami G; Gaidano G; Knowles DM
Blood; 1992 Dec; 80(12):3205-16. PubMed ID: 1361372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]